NEUP·64136E102·US·equity·Healthcare - Biotechnology-Activist
NEUP (NEUPHORIA THERAPEUTICS INC) is held by 8 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($578,685), GEODE CAPITAL MANAGEMENT, LLC ($211,668), CITADEL ADVISORS LLC ($78,677). Net institutional sentiment: Mixed.
See how NEUP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer